A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Participants with DCIS Following Breast Conserving Therapy https://inova.org/clinical-trials/prospective-registry-study-evaluate-effect-dcisionrt-test-treatment-decisions
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy (REG001-09) https://inova.org/clinical-trials/evaluation-tracking-project-prospective-chart-review-patients-treated-radiation
Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing (EA3132) https://inova.org/clinical-trials/phase-II-randomized-trial-radiotherapy-or-without-cisplatin-scchn
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of t3 and t4a (and Selected t4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (Npnscc) (ea3163) https://inova.org/clinical-trials/phase-II-randomized-trial-neoadjuvant-chemotherapy
Evaluation of a Biomarker Test for the Early Molecular Profiling of Lung Cancer Utilizing Cytological Samples (ATLAS DHF 011-003P) https://inova.org/clinical-trials/evaluation-biomarker-test-early-molecular-profiling-lung-cancer-utilizing
Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy https://inova.org/clinical-trials/postoperative-or-salvage-radiotherapy-node-negative-prostate-cancer
A Phase II Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma (PCG PAN009-18) https://inova.org/clinical-trials/phase-II-trial-escalated-dose-proton-radiotherapy-elective-nodal-irradiation
A Phase II trial of SMO/AKT/NF2/CDK inhibitors in progressive meningiomas with SMO/AKT/NF2/CDK pathway mutations (A071401) https://inova.org/clinical-trials/phase-II-trial-smoaktnf2cdk-inhibitors-progressive-meningiomas-smoaktnf2cdk-pathway
The Pancreatic Early Detection Consortium (PRECEDE) https://inova.org/clinical-trials/pancreatic-early-detection-consortium-precede
Redefining The Use Of a FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer (GI 170) https://inova.org/clinical-trials/redefining-use-folfirinox-regimen-front-line-older-patients-metastatic-pancreatic